Aiforia Technologies Oyj (HEL:AIFORIA)

Market Cap	41.27M -60.7%
Revenue (ttm)	3.54M +23.9%
Net Income	-12.67M
EPS	-0.41
Shares Out	37.39M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,816
Open	1.110
Previous Close	1.110
Day's Range	1.080 - 1.118
52-Week Range	1.066 - 3.730
Beta	0.13
Analysts	Sell
Price Target	1.20 (+8.7%)
Earnings Date	Aug 28, 2026

About Aiforia Technologies Oyj

Aiforia Technologies Oyj, together with its subsidiary, Aiforia Inc., provides AI-based image analysis software used in clinical, preclinical, and academic laboratories to pathologists and researchers in Finland, rest of Europe, North America, and internationally. It offers tools for AI-supported diagnostics and visualization of patient samples, as well as automated screening and reporting tools for the treatment of various cancers, such as breast, lung, and prostate cancer; CE-IVD marked Aiforia clinical suite viewer for the clinical pathology...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2013
• Employees: 76
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: AIFORIA

Financial Performance

In 2025, Aiforia Technologies Oyj's revenue was 3.54 million, an increase of 23.95% compared to the previous year's 2.85 million. Losses were -12.67 million, 6.01% more than in 2024.

Analyst Summary

According to 2 analysts, the average rating for AIFORIA stock is "Sell." The 12-month stock price target is €1.20, which is an increase of 8.70% from the latest price.

Price Target

€1.20

(8.70% upside)

Analyst Consensus: Sell

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 9, 2026

Data Sources Report a data error